Cargando…
Transplantation of bone marrow derived macrophages reduces markers of neuropathology in an APP/PS1 mouse model
BACKGROUND: We investigated early hallmarks of putative therapeutic effects following systemic transplantation of bone marrow derived macrophages (BM-M) in APP/PS1 transgenic mice. METHOD: BM-M were transplanted into the tail vein and the animals analysed 1 month later. RESULTS: BM-M transplantation...
Autores principales: | Costa-Marques, Luís, Arnold, Katrin, Pardon, Marie-Christine, Leovsky, Christiane, Swarbrick, Samantha, Fabian, Claire, Stolzing, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790992/ https://www.ncbi.nlm.nih.gov/pubmed/31636901 http://dx.doi.org/10.1186/s40035-019-0173-9 |
Ejemplares similares
-
Distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal health
por: Fabian, Claire, et al.
Publicado: (2017) -
Vaccine Development to Treat Alzheimer's Disease Neuropathology in APP/PS1 Transgenic Mice
por: Carrera, Iván, et al.
Publicado: (2012) -
Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice
por: Yang, Wenjuan, et al.
Publicado: (2018) -
Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease
por: Swarbrick, S., et al.
Publicado: (2019) -
Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling
por: Li, Lei, et al.
Publicado: (2020)